GP
PJP icon

Girard Partners’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Girard Partners’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-200
Closed -$14K – 658
2018
Q3 		$14K Buy
+200
New +$14.4K ﹤0.01% 659

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
MIH
Madison Investment Holdings Madison, Wisconsin $6.16B AUM 11.67% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BCM
Barometer Capital Management Toronto, Ontario, Canada $360M AUM 83.37% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Girard Partners's PJP Position: Q4 2018 in Review

Girard Partners sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2018, closing a stake of 200 shares — an estimated $14K sold.

Girard Partners first reported a position in PJP in Q3 2018 and held it in 1 quarter. The position peaked at $14K in Q3 2018. 91 funds tracked by Wall St. Rank hold PJP as of Q4 2018.

  • Girard Partners reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2018 after selling out during the quarter.
  • Girard Partners sold 200 Invesco Pharmaceuticals ETF shares in Q4 2018, an estimated $14K.
  • Girard Partners first reported a position in Invesco Pharmaceuticals ETF in Q3 2018 and held it in 1 quarter.
  • Girard Partners's Invesco Pharmaceuticals ETF position peaked at $14K in Q3 2018.
  • 91 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2018.

Based on Girard Partners's 13F filing for Q4 2018, filed 11 Feb 2019.